AKT signaling in regulating angiogenesis

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The AKT signaling pathway is a key regulator of cell survival, proliferation, and tumor growth.
• Dysregulation of AKT pathway components like PI3K, PTEN, and Ras is common in human cancers.
• AKT plays a significant role in both normal vascularization and pathological angiogenesis, essential for tumor progression.

Purpose of the Study:

• To review the role and mechanisms of AKT signaling in regulating angiogenesis.
• To explore how AKT influences the expression of key angiogenic factors like VEGF and HIF-1.
• To discuss the therapeutic potential of targeting the AKT pathway for cancer treatment.

Main Methods:

• Literature review of recent studies on AKT signaling and angiogenesis.
• Analysis of molecular mechanisms linking AKT activation to VEGF and HIF-1 expression.
• Examination of upstream and downstream components of the AKT pathway involved in angiogenesis.

Main Results:

• AKT activation is necessary and sufficient for regulating VEGF (Vascular Endothelial Growth Factor) and HIF-1 (Hypoxia-Inducible Factor 1) expression in cancer cells.
• AKT influences VEGF and HIF-1 expression via downstream molecules HDM2 and p70S6K1.
• AKT integrates signals from various upstream factors, including growth factors and oncogenes, to control angiogenesis.

Conclusions:

• Targeting AKT signaling and its downstream effectors presents a novel therapeutic strategy for inhibiting tumor angiogenesis.
• Natural compounds that inhibit AKT activation and VEGF expression show potential for cancer prevention and treatment.
• Understanding AKT's role in angiogenesis is vital for developing future anti-cancer therapies.